OncLive® On Air

S5 Ep31: FDA Approval Insights: Isatuximab Plus Carfilzomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Aug 9, 2021
Ask episode
Chapters
Transcript
Episode notes